https://www.macrotrends.net/stocks/charts/DRMA/dermata-therapeutics/operating-income
Dermata Therapeutics Operating Income 2020-2025 | DRMA | MacroTrends
Dermata Therapeutics operating income from 2020 to 2025. Operating income can be defined as income after operating expenses have been deducted and before...
operating incomedermatatherapeutics20202025
https://www.fiercebiotech.com/keyword/dermata
Dermata | Fierce Biotech
dermatafiercebiotech
https://www.benzinga.com/intraday-update/22/02/25545374/12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's Intraday Session - Dermata Therapeutics (NASDAQ:DRMA) -...
https://www.macrotrends.net/stocks/charts/DRMA/dermata-therapeutics/balance-sheet
Dermata Therapeutics Balance Sheet 2019-2026 | DRMA | MacroTrends
Ten years of annual and quarterly balance sheets for Dermata Therapeutics (DRMA). The balance sheet is a financial report that shows the assets of a business...
balance sheetdermatatherapeutics20192026
https://www.biospace.com/dermata-announces-achievement-of-50-enrollment-in-pivotal-dmt310-phase-3-star-1-clinical-trial-for-acne
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for...
https://www.home.saxo/cs-cz/markets/stocks/drma-xnas
Dermata Therapeutics Inc. akcie | Saxo Bank
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions.
dermatatherapeuticsincakciesaxo
https://www.biospace.com/press-releases/dermata-therapeutics-announces-exercise-of-warrants-for-6-2-million-in-gross-proceeds-priced-at-the-market-under-nasdaq-rules
Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced...
https://www.biospace.com/business/dermata-therapeutics-announces-participation-at-the-h-c-wainwright-26th-annual-global-investment-conference-september-9-11-2024
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment...